-
Merck Sharp & Dohme B.V. v. Warner Chilcott Company LLC et al DC CAFC
- 1:13-cv-02088
- D. Del.
- Judge: Gregory M. Sleet
- Filed: 12/24/2013
- Closed: 12/21/2017
- Latest Docket Entry: 12/21/2017
- PACER
- Docket updated daily
1
Plaintiff
2
Defendants
1
Accused
Product
1
Patent-in-Suit
1,459
Days in
Litigation
-
Merck Sharp & Dohme B.V. v. Warner Chilcott Company LLC et al DC CAFC
- 1:13-cv-02088
- D. Del.
- Judge: Gregory M. Sleet
- Filed: 12/24/2013
- Closed: 12/21/2017
- Latest Docket Entry: 12/21/2017
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Court
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 4 |
A drug delivery system according to claim 1, wherein the amount of progestogenic compound dissolved in the thermoplastic core material is 2 to 5 times the amount necessary for obtaining saturation concentration.
|
Valid
Entry 156 |
| 11 |
A drug delivery system according to claim 5, wherein the core material comprises 0.55 to 0.8% by weight of etonogestrel and 0.12 to 0.18% by weight of ethinyl estradiol.
|
Valid
Entry 156 |
| All Claims |
NA
|
Invalid (103)
Entry 148 |
-
Infringement
Warner Chilcott Company LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| The etonogestrel/ethinyl estradiol vaginal ring | US 5,989,581 A |
4, 11
|
Infringement
Entry 156
|
Warner Chilcott (Us) LLC
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| The etonogestrel/ethinyl estradiol vaginal ring | US 5,989,581 A |
4, 11
|
Infringement
Entry 156
|
